E-commerce Contacto
/contact

Hawes, Endosonografía 4 edición

Robert H. Hawes


  1. Sección II: Mediastino
  2. Cap. 8 Ultrasonido endoscópico en cánceres esofágico y gástrico
Regresar

Capítulo 8 Ultrasonido endoscópico en cánceres esofágico y gástrico

  1. Jemal A, Bray F, Center MMet al., et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
  2. American Cancer Society. Global Cancer Facts & Figures. 3rd ed. Atlanta: American Cancer Society; 2015.
  3. Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2013. Bethesda, MD: National Cancer Institute, http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site; April 2016.
  4. Edgren G, Adami HO, Weiderpass Eet al., et al. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013;62(10):1406–1414.
  5. Hur C, Miller M, Kong CYet al., et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119(6):1149–1158.
  6. Amin MB, Edge SB, Greene FLet al., et al., eds. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.
  7. American Joint Committee on Cancer, accessed https://cancerstaging.org/About/news/Pages/Implementation-of-AJCC-8th-Edition-Cancer-Staging-System.aspx, accessed April 2017.
  8. Westerterp M, Koppert LB, Buskens CJet al., et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005;446:497–504.
  9. Manner H, Pech O, Heldmann Yet al., et al. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastro Hepatol. 2013;11:630–635.
  10. Nentwich MF, von Loga K, Reeh Met al., et al. Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus. J Gastrointest Surg. 2014;18:242–249.
  11. Leggett CL, Lewis JT, Wu TTet al., et al. Clinical and histological determinants of mortality for patients with Barrett’s esophagus-related T1 esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2014;13(4):658–664.
  12. Lee L, Ronellenfitsch U, Hofstetter WLet al., et al. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system. J Am Coll Surg. 2013;217:191–199.
  13. The Paris endoscopic classification of superficial neoplastic lesions. esophagus, stomach, and colon. Gastrointest Endosc. 2003;58(suppl):S3–S43.
  14. Pech O, May A, Manner Het al., et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146:652–660.
  15. Weusten B, Bisschops R, Coron Eet al., et al. Endoscopic management of Barrett’s esophagus: european society of gastrointestinal endoscopy (ESGE) position statement. Endoscopy. 2017;49:e1–e4.
  16. Alvarez Herrero L, Pouw RE, van Vilsteren FGet al., et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy. 2010;42:1030–1036.
  17. Manner H, Pech O, Heldmann Yet al., et al. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc. 2015;29:1888–1896.
  18. Manner H, May A, Pech Oet al., et al. Early Barrett’s carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol. 2008;103:2589–2597.
  19. Dubecz A, Kern M, Solymosi Net al., et al. Predictors of lymph node metastasis in surgically resected T1 Esophageal Cancer. Ann Thorac Surg. 2015;99:1879–1886.
  20. Buskens CJ, Westerterp M, Lagarde SMet al., et al. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc. 2004;60:703–710.
  21. Pennathur A, Farkas A, Krasinskas AMet al., et al. Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg. 2009;87:1048–1054.
  22. Rice TW, Mason DP, Murthy SCet al., et al. T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg. 2007;133:317–324.
  23. Raja S, Rice TW, Goldblum JRet al., et al. Esophageal submucosa: the watershed for esophageal cancer. J Thorac Cardiovasc Surg. 2011;142:1403–1411.
  24. Hagen JA, DeMeester SR, Peters JHet al., et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001;234:520–530.
  25. Lerut T, Nafteux P, Moons Jet al., et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 Ro resections: impact on staging, disease-free survival, and outcome. A plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg. 2004;240:962–974.
  26. Nigro JJ, Hagen JA, DeMeester TRet al., et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg. 1999;117:16–23.
  27. Schroder W, Monig SP, Baldus SEet al., et al. Frequency of nodal metastases to the upper mediastinum in Barrett’s cancer. Ann Surg Oncol. 2002;9:807–811.
  28. Lagarde SM, ten Kate Fiebo JW, Reitsma Johannes Bet al., et al. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol. 2006;24:4347–4355.
  29. D’Journo XB, Doddoli C, Michelet Pet al., et al. Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two field mediastinal lymphadenectomy? Eur J Cardiothorac Surg. 2005;27:697–704.
  30. Kidane B, Coughlin S, Vogt K, Malthaner R. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev. 2015;(5):CD001556.
  31. Fiorica F, Di Bona D, Schepis Fet al., et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut. 2004;53(7):925–930.
  32. Bancewicz J, Clark PI, Smith DBet al., et al. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359:1727–1733.
  33. Walsh TN, Noonan N, Hollywood Det al., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335(7):462–467.
  34. van Hagen P, Hulshof MC, van Lanschot JJet al., et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–2084.
  35. Stahl M, Budach W, Meyer H-Jet al., et al. Esophageal cancer: clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl 5):v46–v49.
  36. Mariette C, Dahan L, Mornex Fet al., et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol. 2014;32(23):2416–2422.
  37. Cooper JS, Guo MD, Herskovic Aet al., et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999;281(17):1623–1627.
  38. Minsky BD, Pajak TF, Ginsberg RJet al., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20(5):1167–1174.
  39. Stahl M, Stuschke M, Lehmann Net al., et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23(10):2310–2317.
  40. Bedenne L, Michel P, Bouche Oet al., et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25(1):1160–1168.
  41. Kutup A, Link BC, Schurr PGet al., et al. Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer. Endoscopy. 2007;39:715–719.
  42. Pech O, Gunter E, Dusemund F, Ell C. Value of high-frequency miniprobes and conventional radial endoscopic ultrasound in the staging of early Barrett’s carcinoma. Endoscopy. 2010;42:98–103.
  43. DeWitt J, Kesler K, Brooks JAet al., et al. Endoscopic ultrasound for esophageal and gastroesophageal junction cancer: impact of increased use of primary neoadjuvant therapy on preoperative locoregional staging accuracy. Dis Esophagus. 2005;18:21–27.
  44. Boniface MM, Wani SB, Schefter TEet al., et al. Multidisciplinary management for esophageal and gastric cancer. Cancer Manag Res. 2016;8:39–44.
  45. van Westreenen HL, Heeren PA, van Dullemen HNet al., et al. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg. 2005;9:54–61.
  46. National comprehensive cancer network (NCCN) clinical practice guidelines in oncology: esophageal and esophagogastric junction cancers. Version 1.2017. Accessed April 2017: https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.
  47. Akdamar M, Eloubeidi MA. A prospective comparison of computerized tomography (CT), 18 fluoro-deoxyglucose positron emission tomography (FDG-PET) and endoscopic ultrasonography (EUS) in the preoperative evaluation of potentially operable esophageal cancer (ECA) patients. Am J Gastroenterol. 2005;98:s5.
  48. van Westreenen HL, Heeren PA, Jager PLet al., et al. Pitfalls of positive findings in staging esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography. Ann Surg Oncol. 2003;10(9). 1100–1105.
  49. Downey RJ, Akhurst T, Ilson Det al., et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol. 2003;21:428–432.
  50. Luketich JD, Schauer PR, Meltzer CCet al., et al. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg. 1997;64:765–769.
  51. Liberale G, Van Laethem JL, Gay Fet al., et al. The role of PET scan in the preoperative management of oesophageal cancer. Eur J Surg Oncol. 2004;30:942–947.
  52. Van Vliet EP, Heijenbrok-Kal MH, Hunink MGet al., et al. Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer. 2008;98(3):547–557.
  53. Lerut T, Flamen P, Ectors Net al., et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg. 2000;232:743–752.
  54. Keswani RN, Early DS, Edmundowicz SAet al., et al. Routine positron emission tomography does not alter nodal staging in patients undergoing EUS-guided FNA for esophageal cancer. Gastrointest Endosc. 2009;69:1210–1217.
  55. van Westreenen HL, Westerterp M, Bossuyt PMet al., et al. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004;22:3805–3812.
  56. Westerterp M, Van Westreenen HL, Sloof GWet al., et al. Role of positron emission tomography in the (re-)staging of oesophageal cancer. Scand J Gastroenterol Suppl. 2006;41:116–122.
  57. Crabtree TD, Yacoub WN, Puri Vet al., et al. Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival. Ann Thorac Surg. 2011;91:1509–1515.
  58. Ajani JA, D’Amico JA, Almhanna Ket al., et al. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw. 2015;13:194–227.
  59. Puli SR, Reddy JB, Bechtold MLet al., et al. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol. 2008;14:1479–1490.
  60. Polkowski M. Endosonographic staging of upper intestinal malignancy. Best Pract Res Clin Gastroenterol. 2009;23:649–661.
  61. Kelly S, Harris KM, Berry Eet al., et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut. 2001;49:534–539.
  62. Pech O, May A, Gunter Eet al., et al. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett’s esophagus. Am J Gastroenterol. 2006;101:2223–2229.
  63. Sandha GS, Severin D, Postema Eet al., et al. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography and EUS. Gastrointest Endosc. 2008;67:402–409.
  64. Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am. 2000;10:471–485.
  65. Choi J, Kim SG, Kim JSet al., et al. Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer. Surg Endosc. 2010;24:1380–1386.
  66. Sihvo EI, Rasanen JV, Knuuti MJet al., et al. Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not locoregional disease. J Gastrointest Surg. 2004;8:988–996.
  67. Pfau PR, Perlman SB, Stanko Pet al., et al. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography. Gastrointest Endosc. 2007;65(3):377–384.
  68. Lowe VJ, Booya F, Fletcher JGet al., et al. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol. 2005;7:422–430.
  69. McDonough PB, Jones DR, Shen KRet al., et al. Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study. Am J Gastroenterol. 2008;103:570–574.
  70. Siemsen M, Svendsen LB, Knigge Uet al., et al. A prospective randomized comparison of curved array and radial echoendoscopy in patients with esophageal cancer. Gastrointest Endosc. 2003;58:671–676.
  71. Takahashi M, Shimizu Y, Ono Met al., et al. Endoscopic diagnosis of early neoplasia of the esophagus with narrow band imaging: correlations among background coloration and iodine staining findings. J Gastroenterol Hepatol. 2014;29:762–768.
  72. Chedgy FJQ, Subramaniam S, Kandiah Ket al., et al. Acetic acid chromoendoscopy: improving neoplasia detection in Barrett’s esophagus. World J Gastroenterol. 2016;22(25):5753–5760.
  73. Van Dam J, Rice TW, Catalano MFet al., et al. High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation. Cancer. 1993;71:2910–2917.
  74. Pfau PR, Ginsberg GG, Lew RJet al., et al. Esophageal dilation for endosonographic evaluation of malignant esophageal strictures is safe and effective. Am J Gastroenterol. 2000;95:2813–2815.
  75. Bang JY, Ramesh J, Hasan Met al., et al. Endoscopic ultrasonography is no required for staging malignant esophageal strictures that preclude the passage of a diagnostic gastroscope. Dig Endosc. 2016;28:650–656.
  76. Qumseya BJ, Brown J, Abraham Met al., et al. Diagnostic performance of EUS in predicting advanced cancer among patients with Barrett’s esophagus and high-grade dysplasia/early adenocarcinoma: systematic review and meta-analysis. Gastrointest Endosc. 2015;81:865–874.
  77. Lerut TE, de Leyn P, Coosemans Wet al., et al. Advanced esophageal carcinoma. World J Surg. 1994;18:379–387.
  78. Waterman TA, Hagen JA, Peters JHet al., et al. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma. Ann Thorac Surg. 2004;78:1161–1169.
  79. Rizk N, Venkatraman E, Park Bet al., et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg. 2006;132:1374–1381.
  80. Natsugoe S, Yoshinaka H, Shimada Met al., et al. Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma. Ann Surg. 2001;234(5):613–618.
  81. Catalano MF, Sivak MVJ, Rice Tet al., et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442–446.
  82. Chen VK, Eloubeidi MA. Endoscopic ultrasound-guided fine needle aspiration is superior to lymph node echofeatures: a prospective evaluation of mediastinal and peri-intestinal lymphadenopathy. Am J Gastroenterol. 2004;99:628–633.
  83. Bhutani MS, Hawes RH, Ho man BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc. 1997;45:474–479.
  84. Vazquez-Sequeiros E, Levy MJ, Clain JEet al., et al. Routine vs. selective EUS-guided FNA approach for preoperative nodal staging of esophageal cancer. Gastrointest Endosc. 2006;63(2):204–211.
  85. Prenzel KL, Bollschweiler E, Schröder Wet al., et al. Prognostic relevance of skip metastases in esophageal cancer. Ann Thorac Surg. 2010;90(5):1662–1667.
  86. Sgourakis G, Gockel I, Lyros Oet al., et al. Detection of lymph node metastases in esophageal cancer. Expert Rev Anticancer Ther. 2011;11(4):601–612.
  87. Mortensen MB, Pless T, Durup Jet al., et al. Clinical impact of endoscopic ultrasound-guided fine needle aspiration biopsy in patients with upper gastrointestinal tract malignancies. A prospective study. Endoscopy. 2001;33:478–483.
  88. McGrath K, Brody D, Luketich Jet al., et al. Detection of unsuspected left hepatic lobe metastases during EUS staging of cancer of the esophagus and cardia. Am J Gastroenterol. 2006;101:1742–1746.
  89. Vazquez-Sequeiros E, Wiersema MJ, Clain JEet al., et al. Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology. 2003;125:1626–1635.
  90. Takubo K, Sasajima K, Yamashita Ket al., et al. Double muscularis mucosae in Barrett’s esophagus. Hum Pathol. 1991;22:1158–1161.
  91. Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon Tet al., et al. Endoscopic submucosal dissection: european society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2015;47:829–854.
  92. Rice TW, Zuccaro Jr. G, Adelstein DJet al., et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg. 1998;65:787–792.
  93. Stein HJ, Feith M, Mueller Jet al., et al. Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg. 2000;232:733–742.
  94. Pech O, Gunter E, Ell C. Endosonography of high-grade intra-epithelial neoplasia/early cancer. Best Pract Res Clin Gastroenterol. 2009;23:639–647.
  95. Watanabe H, Komukai S, Ajioka Yet al., et al. Histopathology of m3 and sm1 invasive squamous cell carcinoma of the esophagus with special reference to endoscopic resection. Stomach and Intestine. 1998;33:1001–1009.
  96. Kashimura H, Watanabe H, Yoichi Ajioka Yet al., et al. The risk factors for nodal micrometastasis of submucosal invasive gastric carcinoma with special reference to assessment of the indication for endoscopic treatment. Gastric Cancer. 1999;2:33–39.
  97. Pouw RE, Heldoorn N, Herrero LAet al., et al. Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases. Gastrointest Endosc. 2011;73:662–668.
  98. Young PE, Gentry AB, Acosta RDet al., et al. Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin Gastroenterol Hepatol. 2010;8:1037–1041.
  99. Barbour AP, Jones M, Brown Iet al., et al. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol. 2010;17:2494–2502.
  100. Thosani N, Singh H, Kapadia Aet al., et al. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis. Gastrointest Endosc. 2012;75:242–253.
  101. Fernández-Sordo JO, Konda VJA, Chennat Jet al., et al. Is endoscopic ultrasound (EUS) necessary in the pre-therapeutic assessment of Barrett’s esophagus with early neoplasia. J Gastrointest Oncol. 2012;3(4):314–321.
  102. Chemaly M, Scalone O, Durivage Get al., et al. Miniprobe EUS in the pretherapeutic assessment of early esophageal neoplasia. Endoscopy. 2008;40(1):2–6.
  103. May A, Guenter E, Roth Fet al., et al. Accuracy of staging in oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut. 2004;53:634–640.
  104. Pech O, Gossner L, Manner Het al., et al. Prospective evaluation of the macroscopic types and location of early Barrett’s neoplasia in 380 lesions. Endoscopy. 2007;39:588–593.
  105. Peters FP, Brakenhoff KP, Curvers WLet al., et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett’s esophagus. Gastrointest Endosc. 2008;67:604–609.
  106. Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2012;107:850–862.
  107. Fitzgerald RC, di Pietro M, Ragunath Ket al., et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.
  108. Sarkaria IS, Rizk NP, Bains MSet al., et al. Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer. Ann Surg. 2009;249:764–767.
  109. Ribeiro A, Franceschi D, Parra Jet al., et al. Endoscopic ultrasound restaging after neoadjuvant chemotherapy in esophageal cancer. Am J Gastroenterol. 2006;101(6):1216–1221.
  110. Cerfolio RJ, Bryant AS, Ohja Bet al., et al. The accuracy of endoscopic ultra-sonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg. 2005;129:1232–1241.
  111. Swisher SG, Maish M, Erasmus JJet al., et al. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg. 2004;78(4):1152–1160.
  112. Chong AK, Caddy GR, Desmond PV, Chen RY. Prospective study of the clinical impact of EUS. Gastrointest Endosc. 2005;62:399–405.
  113. Mortensen MB, Edwin B, Hünerbein Met al., et al. Impact of endoscopic ultrasonography (EUS) on surgical decision-making in upper gastrointestinal tract cancer: an international ulticentre study. Surg Endosc. 2007;21:431–438.
  114. Giovannini M, Monges G, Seitz JFet al., et al. Distant lymph node metastases in esophageal cancer: impact of endoscopic ultrasound-guided biopsy. Endoscopy. 1999;31:536–540.
  115. Marsman WA, Brink MA, Bergman JJet al., et al. Potential impact of EUS-FNA staging of proximal lymph nodes in patients with distal esophageal carcinoma. Endoscopy. 2006;38:825–829.ç
  116. Shumaker DA, de Garmo P, Faigel DO. Potential impact of preoperative EUS on esophageal cancer management and cost. Gastrointest Endosc. 2002;56:391–396.
  117. Hadzijahic N, Wallace MB, Hawes RHet al., et al. CT or EUS for the initial staging of esophageal cancer? A cost minimization analysis. Gastrointest Endosc. 2000;52:715–720.
  118. Harewood GC, Wiersema MJ. A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer. Am J Gastroenterol. 2002;97:452–458.
  119. Russell IT, Edwards RT, Gliddon AEet al., et al. Cancer of oesophagus or gastricus—new assessment of technology of endosonography (COGNATE): report of pragmatic randomised trial. Health Technol Assess. 2013;17(39).
  120. Harewood GC, Kumar KS. Assessment of clinical impact of endoscopic ultrasound on esophageal cancer. J Gastroenterol Hepatol. 2004;19(4):433–439.
  121. Fockens P, van den Brande JH, van Dullemen MHet al., et al. Endosonographic T-staging of esophageal carcinoma: a learning curve. Gastrointest Endosc. 1996;44:58–62.
  122. van Vliet EP, Eijkemans MJ, Poley JWet al., et al. Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers. Gastrointest Endosc. 2006;63(7):938–947.
  123. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2017;67:7–30.
  124. Ferlay J, Soerjomataram, Dikshit Ret al., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
  125. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
  126. Den Hoed CM, Kuipers EJ. Gastric cancer: how can we reduce the incidence of this disease? Curr Gastroenterol Rep. 2016;18:34.
  127. Hamashima C, Shabana M, Okada Ket al., et al. Mortality reduction from gastric cancer by endoscopic and radiographic screening. Cancer Sci. 2015;106:1744–1749.
  128. Botet J, Lightdale C, Zauber Aet al., et al. Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology. 1991;181:426–432.
  129. Sussman S, Halvorsen RJ, Illescas Fet al., et al. Gastric adenocarcinoma: CT versus surgical staging. Radiology. 1988;167:335–340.
  130. Power D, Schattner M, Gerdes Het al., et al. Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg. 2009;208:173–178.
  131. Mouri R, Yoshida S, Tanaka Set al., et al. Usefulness of endoscopic ultrasonography in determining the depth of invasion and indication for endoscopic treatment of early gastric cancer. J Clin Gastroenterol. 2009;43:318–322.
  132. Blackshaw G, Lewis W, Hopper Aet al., et al. Prospective comparison of endosonography, computed tomography, and histopathological stage of junctional oesophagogastric cancer. Clin Radiol. 2008;63:1092–1098.
  133. Ganpathi I, So J, Ho K. Endoscopic ultrasonography for gastric cancer: does it influence treatment? Surg Endosc. 2006;20:559–562.
  134. Polkowski M, Palucki J, Wronska Eet al., et al. Endosonography versus helical computed tomography for locoregional staging of gastric cancer. Endoscopy. 2004;36:617–623.
  135. Sultan J, Robinson S, Hayes Net al., et al. Endoscopic ultrasonography-detected low-volume ascites as a predictor of inoperability for oesophagogastric cancer. Br J Surg. 2008;95:1127–1130.
  136. Singh P, Mukhopadhyay P, Bhatt Bet al., et al. Endoscopic ultrasound versus CT scan for detection of the metastases to the liver: results of a prospective comparative study. J Clin Gastroenterol. 2009;43:367–373.
  137. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–123.
  138. Sarela AI, Lefkowitz R, Brennan MF, Karpeh MS. Selection of patients with gastric adenocarcinoma for laparoscopic staging. Am J Surg. 2006;191:134–138.
  139. Mezhir JJ, Shah MA, Jacks LMet al., et al. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol. 2010;17:3173–3180.
  140. Bentrem D, Gerdes H, Tang Let al., et al. Clinical correlation of endoscopic ultrasonography with pathologic stage and outcome in patients undergoing curative resection for gastric cancer. Ann Surg Oncol. 2007;14(6):1853–1859.
  141. Okada K, Fujisaki J, Kasuga Aet al., et al. Endoscopic ultrasonography is valuable for identifying early gastric cancers meeting expanded-indication criteria for endoscopic submucosal dissection. Surg Endosc. 2011;25(3):841–848.
  142. Wang J, Hsieh J, Huang Yet al., et al. Endoscopic ultrasonography for preoperative locoregional staging and assessment of resectability in gastric cancer. Clin Imaging. 1998;22:355–359.
  143. Prasad P, Schmulewitz N, Patel Aet al., et al. Detection of occult liver metastases during EUS for staging of malignancies. Gastrointest Endosc. 2004;59:49–53.
  144. Yoshida S, Tanaka S, Kunihiro Ket al., et al. Diagnostic ability of high-frequency ultrasound probe sonography in staging early gastric cancer, especially for submucosal invasion. Abdom Imaging. 2005;30:518–523.
  145. Gotoda T, Yanagisawa A, Sasako Met al., et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–225.
  146. Choi J, Kim SG, Im JPet al., et al. Comparison of endoscopic ultrasonography and conventional endoscopy for prediction of depth of tumor invasion in early gastric cancer. Endoscopy. 2010;42:705–713.
  147. Choi J, Kim SG, Im JPet al., et al. Endoscopic prediction of tumor invasion depth in early gastric cancer. Gastrointest Endosc. 2011;73:917–927.
  148. Hölscher A, Drebber U, Mönig Set al., et al. Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration. Ann Surg. 2009;250:791–797.
  149. Folli S, Morgagni P, Roviello Fet al., et al. Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the italian research group for gastric cancer (IRGGC). Jpn J Clin Oncol. 2001;31:495–499.
  150. Son SY, Park JY, Ryu KWet al., et al. The risk factors for lymph node metastasis in early gastric cancer patients who underwent endoscopic resection: is the minimal lymph node dissection applicable? A retrospective study. Surg Endosc. 2013;27:3247–3253.
  151. Lian J, Chen S, Zhang Yet al., et al. A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer. Gastrointest Endosc. 2012;76:763–770.
  152. Park YM, Cho E, Kang HYet al., et al. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc. 2011;25:2666–2677.
  153. Facciorusso A, Antonino M, Di Maso Met al., et al. Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: a meta-analysis. World J Gastrointest Endosc. 2014;6:555–563.
  154. Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon Tet al., et al. Endoscopic submucosal dissection: european society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2015;47:829–854.
  155. Gotoda T, Iwasaki M, Kusano Cet al., et al. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg. 2010;97:868–871.
  156. Min YW, Min BH, Lee JH, Kim JJ. Endoscopic treatment for early gastric cancer. World J Gastroenterol. 2014;20(16):4566–4573.
  157. Cunningham D, Allum W, Stenning Set al., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.
  158. Macdonald J, Smalley S, Benedetti Jet al., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–730.
  159. Kwee R, Kwee T. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol. 2007;25:2107–2116.
  160. Habermann C, Weiss F, Riecken Ret al., et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology. 2004;230:465–471.
  161. Hwang SW, Lee DH, Lee SHet al., et al. Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. J Gastroenterol Hepatol. 2010;25:512–518.
  162. Mocellin S, Pasquali S. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database Syst Rev. 2015;(2). CD009944.
  163. Cardoso R, Coburn N, Seevaratnam Ret al., et al. A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer. Gastric Cancer. 2012;15(suppl 1):S19–S26.
  164. Pei Q, Wang L, Pan Jet al., et al. Endoscopic ultrasonography for staging depth of invasion in early gastric cancer: a meta-analysis. J Gastroenterol Hepatol. 2015;30:1566–1573.
  165. Puli S, Batapati Krishna Reddy J, Bechtold Met al., et al. How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review. World J Gastroenterol. 2008;14:4011–4019.
  166. Hassan H, Vilmann P, Sharma V. Impact of EUS-guided FNA on management of gastric carcinoma. Gastrointest Endosc. 2010;71:500–504.
  167. Chang K, Albers C, Nguyen P. Endoscopic ultrasound-guided fine needle aspiration of pleural and ascitic fluid. Am J Gastroenterol. 1995;90:148–150.
  168. Lee Y, Ng E, Hung Let al., et al. Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut. 2005;54:1541–1545.
  169. Meining A, Dittler H, Wolf Aet al., et al. You get what you expect? A critical appraisal of imaging methodology in endosonographic cancer staging. Gut. 2002;50:599–603.
  170. Meining A, Rösch T, Wolf Aet al., et al. High interobserver variability in endosonographic staging of upper gastrointestinal cancers. Z Gastroenterol. 2003;41:391–394.
  171. Kim J, Song K, Youn Yet al., et al. Clinicopathologic factors influence accurate endosonographic assessment for early gastric cancer. Gastrointest Endosc. 2007;66:901–908.
  172. Meyer L, Meyer F, Schmidt Uet al., et al. Endoscopic ultrasonography (EUS) in preoperative staging of gastric cancer—demand and reality. Pol Przegl Chir. 2012;84:152–157.
  173. Hur J, Park MS, Lee JHet al., et al. Diagnostic accuracy of multidetector row computed tomography in T- and N staging of gastric cancer with histopathologic correlation. J Comp Assist Tomogr. 2006;30(3):372–377.
  174. Kawaguchi T, Ichikawa D, Komatsu Set al., et al. Clinical evaluation of JCGC and TNM staging on multidetector-row computed tomography in preoperative nodal staging of gastric cancer. Hepatogastroenterology. 2011;58(3):838–841.
  175. Kim AY, Kim HJ, Ha HK. Gastric cancer by multidetector row CT: preoperative staging. Abdom Imaging. 2005;30(4):465–472.
  176. Kumano S, Murakami T, Kim Tet al., et al. T staging of gastric cancer: role of multi-detector row CT. Radiology. 2005;237(3):961–966.
  177. Stell DA, Carter CR, Stewart I, Anderson JR. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg. 1996;83(9):1260–1262.
  178. Chen CY, Wu DC, Kang WY, Hsu JS. Staging of gastric cancer with 16-channel MDCT. Abdom Imaging. 2006;31(5):514–520.
  179. Chen CY, Hsu JS, Wu DCet al., et al. Gastric cancer: preoperative local staging with 3D multi-detector row CT—correlation with surgical and histopathologic results. Radiology. 2007;242:472–482.
  180. Yang DM, Kim HC, Jin Wet al., et al. 64 Multidetector-row computed tomography for preoperative evaluation of gastric cancer: histological correlation. J Comp Assist Tomogr. 2007;31(1):98–103.
  181. Seevaratnam R, Cardoso R, McGregor Cet al., et al. How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis. Gastric Cancer. 2012;15(suppl 1):S3–S18.
  182. Kagedan DJ, Frankul F, El-Sedfy Aet al., et al. Negative predictive value of preoperative computed tomography in determining pathologic local invasion, nodal disease, and abdominal metastases in gastric cancer. Curr Oncol. 2016;23(4):273–279.
  183. Ha TK, Choi YY, Song SY, Kwon SJ. F18-fluorodeoxyglucose-positron emission tomography and computed tomography is not accurate in preoperative staging of gastric cancer. J Korean Surg Soc. 2011;81(2):104–110.
  184. Kim EY, Lee WJ, Choi Det al., et al. The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT. Eur J Radiol. 2011;79(2):183–188.
  185. Kang BC, Kim JH, Lee DYet al., et al. Value of the dynamic and delayed MR sequence with Gd-DTPA in the T-staging of stomach cancer: correlation with the histopathology. Abdom Imaging. 2000;25(1):14–24.
  186. Sohn KM, Lee JM, Lee SYet al., et al. Comparing MR imaging and CT in the staging of gastric carcinoma. AJR Am J Roentgenol. 2000;174(6):1551–1557.
  187. Giganti F, Orsenigo E, Arcidiacono PGet al., et al. Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography. Gastric Cancer. 2016;19(1):216–225.
  188. Kwee R, Kwee T. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer. 2009;12:6–22.
  189. Wang Z, Chen JQ. Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review. BMC Gastroenterol. 2011;11:19.
  190. Kayaalp C, Arda K, Orug T, Ozcay N. Value of computed tomography in addition to ultrasound for preoperative staging of gastric cancer. Eur J Surg Oncol. 2002;28:540–543.
  191. Burke E, Karpeh M, Conlon K, Brennan M. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg. 1997;225:262–267.
  192. Power D, Schattner M, Gerdes Het al., et al. Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer. J Am Coll Surg. 2009;208:173–178.
  193. Serrano OK, Huang K, Ng Net al., et al. Correlation between preoperative endoscopic ultrasound and surgical pathology staging of gastric adenocarcinoma: a single institution retrospective review. J Surg Oncol. 2016;113(1):42–45.
  194. Park S, Lee J, Kim Cet al., et al. Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Cancer. 2008;112:2368–2376.
  195. Papaxoinis G, Papageorgiou S, Rontogianni Det al., et al. Primary gastrointestinal non-Hodgkin’s lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma. 2006;47:2140–2146.
  196. Koch P, del Valle F, Berdel Wet al., et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German multicenter study GIT NHL 01/92. J Clin Oncol. 2001;19:3861–3873.
  197. Suekane H, Iida M, Yao Tet al., et al. Endoscopic ultrasonography in primary gastric lymphoma: correlation with endoscopic and histologic findings. Gastrointest Endosc. 1993;39:139–145.
  198. Palazzo L, Roseau G, Ruskone-Fourmestraux Aet al., et al. Endoscopic ultrasonography in the local staging of primary gastric lymphoma. Endoscopy. 1993;25:502–508.
  199. Van Dam J. The role of endoscopic ultrasonography in monitoring treatment: response to chemotherapy in lymphoma. Endoscopy. 1994;26:772–773.
  200. Hordijk M. Restaging after radiotherapy and chemotherapy: value of endoscopic ultrasonography. Gastrointest Endosc Clin N Am. 1995;5:601–608.
  201. Caletti G, Fusaroli P, Togliani Tet al., et al. Endosonography in gastric lymphoma and large gastric folds. Eur J Ultrasound. 2000;11:31–40.
  202. Zullo A, Hassan C, Andriani Aet al., et al. Primary low-grade and high-grade gastric MALT-lymphoma presentation. J Clin Gastroenterol. 2010;44(5):340–344.
  203. De Paepe P, Achten R, Verhoef Get al., et al. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas. J Clin Oncol. 2005;23:7060–7068.
  204. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology. 1992;102:1628–1638.
  205. Cogliatti S, Schmid U, Schumacher Uet al., et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology. 1991;101:1159–1170.
  206. Parsonnet J, Hansen S, Rodriguez Let al., et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330:1267–1271.
  207. Fischbach W, Goebeler-Kolve M, Dragosics Bet al., et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut. 2004;53:34–37.
  208. Koch P, del Valle F, Berdel Wet al., et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19:3861–3873.
  209. Komorowski R, Caya J, Geenen J. The morphologic spectrum of large gastric folds: utility of the snare biopsy. Gastrointest Endosc. 1986;32:190–192.
  210. Ikoma N, Badgwell BD, Mansfield PF. Multimodality treatment of gastric lymphoma. Surg Clin North Am. 2017;97(2):405–420.
  211. Kuldau JG, Holman PR, Savides TJ. Diagnosis and management of gastrointestinal lymphoma. In: Faigel DO, Kochman ML, eds. Endoscopic Oncology: Gastrointestinal Endoscopy and Cancer Management. 1st ed. Toronto, NJ: Humana Press; 2006:139–149. [Chapter 13].
  212. Wiersema M, Gatzimos K, Nisi R, Wiersema L. Staging of non-Hodgkin’s gastric lymphoma with endosonography-guided fine-needle aspiration biopsy and flow cytometry. Gastrointest Endosc. 1996;44:734–736.
  213. Vander Noot MR, Eloubeidi MA, Chen VKet al., et al. Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer. 2004;102:157–163.
  214. Caletti G, Ferrari A, Bocus Pet al., et al. Endoscopic ultrasonography in gastric lymphoma. Schweiz Med Wochenschr. 1996;126:819–825.
  215. Yeh H, Chen G, Chang Wet al., et al. Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe. J Gastroenterol Hepatol. 2003;18:162–167.
  216. Swerdlow SH, Campo E, Pileri SAet al., et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–2390.
  217. Cheson BD, Fisher RI, Barrington SFet al., et al. Recommendations for initial evaluation, staging and response assessment of Hodgkin and non-Hodgkin lymphoma—the lugano classification. J Clin Oncol. 2014;32(27):3059–3067.
  218. Taal B, Boot H, van Heerde Pet al., et al. Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept. Gut. 1996;39:556–561.
  219. Fischbach W, Goebeler-Kolve ME, Greiner A. Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: results of a prospective, multicenter study comparing EUS with histopathologic stage. Gastrointest Endosc. 2002;56:696–700.
  220. Caletti G, Ferrari A, Brocchi E, Barbara L. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma. Surgery. 1993;113:14–27.
  221. Yasuda I, Tsurumi H, Omar Set al., et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy for lymphadenopathy of unknown origin. Endoscopy. 2006;38:919–924.
  222. Wiersema M, Gatzimos K, Nisi R, Wiersema L. Staging of non-Hodgkin’s gastric lymphoma with endosonography-guided fine-needle aspiration biopsy and flow cytometry. Gastrointest Endosc. 1996;44:734–736.
  223. Pavlick A, Gerdes H, Portlock C. Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors. J Clin Oncol. 1997;15:1761–1766.
  224. Sackmann M, Morgner A, Rudolph Bet al., et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology. 1997;113:1087–1090.
  225. Ruskoné-Fourmestraux A, Lavergne A, Aegerter Pet al., et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut. 2001;48:297–303.
  226. Nakamura S, Matsumoto T, Suekane Het al., et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut. 2001;48:454–460.
  227. Caletti G, Zinzani P, Fusaroli Pet al., et al. The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma. Aliment Pharmacol Ther. 2002;16:1715–1722.
  228. Levy M, Copie-Bergman C, Traulle Cet al., et al. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol. 2002;97:292–297.
  229. Zucca E, Cavalli F. Are antibiotics the treatment of choice for gastric lymphoma? Curr Hematol Rep. 2004;3:11–16.
  230. Püspök A, Raderer M, Chott Aet al., et al. Endoscopic ultrasound in the follow up and response assessment of patients with primary gastric lymphoma. Gut. 2002;51:691–694.
  231. Yeh H, Chen G, Chang Wet al., et al. Long-term follow up of gastric low-grade mucosa-associated lymphoid tissue lymphoma by endosonography emphasizing the application of a miniature ultrasound probe. J Gastroenterol Hepatol. 2003;18:162–167.
  232. Di Raimondo F, Caruso L, Bonanno Get al., et al. Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma? Ann Oncol. 2007;18:351–356.
  233. Vetro C, Romano A, Chiarenza Aet al., et al. Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-up. Hematol Oncol. 2012;30:180–185.
  234. Fusaroli P, Buscarini E, Peyre Set al., et al. Interobserver agreement in staging gastric malt lymphoma by EUS. Gastrointest Endosc. 2002;55:662–668.
  235. Kimmey M, Martin R, Haggitt Ret al., et al. Histologic correlates of gastrointestinal ultrasound images. Gastroenterology. 1989;96:433–441.
  236. Feng J, Al-Abbadi M, Kodali U, Dhar R. Cytologic diagnosis of gastric linitis plastica by endoscopic ultrasound guided fine-needle aspiration. Diagn Cytopathol. 2006;34:177–179.
  237. Levine M, Kong V, Rubesin Set al., et al. Scirrhous carcinoma of the stomach: radiologic and endoscopic diagnosis. Radiology. 1990;175:151–154.
  238. Fujishima H, Misawa T, Chijiwa Yet al., et al. Scirrhous carcinoma of the stomach versus hypertrophic gastritis: findings at endoscopic US. Radiology. 1991;181:197–200.
  239. Feng J, Al-Abbadi M, Kodali U, Dhar R. Cytologic diagnosis of gastric linitis plastica by endoscopic ultrasound guided fine-needle aspiration. Diagn Cytopathol. 2006;34:177–179.
  240. Dempsey P, Goldenring J, Soroka Cet al., et al. Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier’s disease: supportive evidence form humans and transgenic mice. Gastroenterology. 1992;103:1950–1963.
  241. Wolfsen H, Carpenter H, Talley N. Menetrier’s disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology. 1993;104:1310–1319.
  242. Sundt TR, Compton C, Malt R. Ménétrier’s disease. A trivalent gastropathy. Ann Surg. 1988;208:694–701.
  243. Hizawa K, Kawasaki M, Yao Tet al., et al. Endoscopic ultrasound features of protein-losing gastropathy with hypertrophic gastric folds. Endoscopy. 2000;32:394–397.
  244. Thomas T, Kaye PV, Ragunath K, Aithal GP. Endoscopic-ultrasound-guided mural trucut biopsy in the investigation of unexplained thickening of esophagogastric wall. Endoscopy. 2009;41:335–339.
  245. Mendis R, Gerdes H, Lightdale C, Botet J. Large gastric folds: a diagnostic approach using endoscopic ultrasonography. Gastrointest Endosc. 1994;40:437–441.
  246. Gines A, Pellise M, Fernandez-Esparrach Get al., et al. Endoscopic ultrasonography in patients with large gastric folds at endoscopy and biopsies negative for malignancy: predictors of malignant disease and clinical impact. Am J Gastroenterol. 2006;101:64–69.
  247. Okada M, Iizuka Y, Oh Ket al., et al. Gastritis cystica profunda presenting as giant gastric mucosal folds: the role of endoscopic ultrasonography and mucosectomy in the diagnostic work-up. Gastrointest Endosc. 1994;40:640–644.
Regresar